Monthly Archives: October 2023

Ascentage Pharma and AstraZeneca Enter into Clinical Collaboration on the Registrational Phase III Study of Bcl-2 Inhibitor Lisaftoclax in Combination with BTK Inhibitor Acalabrutinib in Treatment-Naïve Patients with First-Line CLL/SLL

SUZHOU, China, and ROCKVILLE, Md., Oct. 15, 2023 /PRNewswire/ — Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has entered into a clinical collaboration with AstraZeneca Investment (China) Co., Ltd. (or “AstraZeneca”). The two companies will jointly conduct […]

LASG seals private hospital over unscreened blood

By Chioma Obinna LAGOS—Lagos State Blood Transfusion Service, LSBTS, said it has shut a private Hospital, located at Ago-Okota, in Oshodi-Isolo Local Government Area of the state, for allegedly collecting and transfusing unscreened blood. The Executive Secretary of LSBTS, Dr. Bodunrin Osikomaiya, who disclosed this, yesterday, said the health facility was sealed by LSBTS and […]

Harpoon Therapeutics to Host Webcast Reviewing HPN328 Interim Data Presented at ESMO Congress 2023 on October 23, 2023

SOUTH SAN FRANCISCO, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (Nasdaq: HARP), a clinical-stage immunotherapy company developing novel T cell engagers, today announced that it will host a live webcast at 8:00 a.m. ET / 2:00 p.m. CEST on Monday, October 23, 2023 to review interim monotherapy data from its Phase 1/2 clinical […]

Bifidobacteria metabolize lactulose to optimize gut metabolites and prevent systemic infection in patients with liver disease

Abstract Progression of chronic liver disease is precipitated by hepatocyte loss, inflammation and fibrosis. This process results in the loss of critical hepatic functions, increasing morbidity and the risk of infection. Medical interventions that treat complications of hepatic failure, including antibiotic administration for systemic infections and lactulose treatment for hepatic encephalopathy, can impact gut microbiome […]

Season of Blood Twitch Drops: Earn the Orichalcum Collection

Season of Blood rushes into Sanctuary on October 17 at 10 a.m. PDT, ushering in a new era of vampiric nightmares to cull and 4 weeks of Twitch Drops to earn! Show support for your favorite streamers by watching them stamp out the fanged invasion—you’ll earn armaments from the Oricalchum collection fit for striking fear […]

Nanotechnology helps chemo pass the blood-brain barrier

Infiltrative glioma cells are protected against commonly used anti-cancer drugs like paclitaxel, which cannot cross the blood-brain barrier (BBB). Using mouse models, UT Southwestern and UT Dallas researchers coated gold nanoparticles (NP) with an antibody targeting them to the brain endothelium. Picosecond laser stimulation of the NP through an intact skull caused a vibration excitation of […]

Top in cardiology: Remote ICD deactivation; FDA OKs next-gen cardiovascular CT scanners

October 16, 2023 1 min read Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . <button type="button" class="btn btn-primary" data-loading-text="Loading ” data-action=”subscribe”> Subscribe Added to email alerts We were unable to process your request. […]

NeuroFrance 2023 — from basic neuroscience to translational discoveries

After the hindrance imposed by the COVID-19 pandemic, neuroscience research pushed forward. NeuroFrance 2023 took place as an in-person meeting and highlighted current and future strategies for exploring the brain and its pathologies, including a strong pathway to mental health research. Every 2 years, at the beginning of summer, NeuroFrance, the largest neuroscience conference in […]